HDAX Therapeutics
www.hdaxtx.com
Innovation Type:
Therapeutics
Cancer Type:
Other
Funding Stage:
Proof Of Concept
Fund:
Prospects
A blood-brain barrier permeable HDAC6 selective inhibitors for CNS cancers based on proprietary technology that unlocks novel binding mechanism for improved next-gen targeting.